US Justice files suit charging J&J paid kickbacks to induce prescriptions
This article was originally published in Scrip
Executive Summary
Federal prosecutors in the US have filed a lawsuit charging that Johnson & Johnson paid "tens of millions" of dollars in kickbacks to induce Omnicare, a provider of pharmacy services, to purchase and recommend J&J drugs, including the antipsychotic Risperdal (risperidone), to nursing homes.